| Nov 20 |
More companies covering weight loss drugs for their employees
|
| Nov 20 |
Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
|
| Nov 20 |
Is Novo Nordisk Stock a Buy Right Now?
|
| Nov 20 |
RFK Jr. Sparks New Worries About Obesity Drugs. Here’s What Investors Should Focus on Instead.
|
| Nov 19 |
Novo Nordisk semaglutide phase 3 trial for MASH meets primary endpoints
|
| Nov 19 |
Sector Update: Health Care Stocks Decline
|
| Nov 19 |
Novo Nordisk Unusual Options Activity For November 19
|
| Nov 19 |
Sector Update: Health Care Stocks Mixed Tuesday Afternoon
|
| Nov 19 |
Novo Erases 2024 Gain, Wiping Out $210 Billion in Value
|
| Nov 19 |
Market Chatter: Eli Lilly, Novo Nordisk Press Employers to Cover the Cost of Weight-Loss Drugs
|
